Results 1 to 10 of about 12,151 (157)

Impact of Severe COVID-19 on Interstitial Lung Disease in Autoimmune Systemic Diseases. [PDF]

Respirol Case Rep
In this multicentre case series of 27 patients with autoimmune systemic diseases, severe COVID‐19 pneumonia led to marked interstitial lung disease (ILD) worsening, with new‐onset or progressive ILD in all survivors and NSIP‐to‐UIP transition in six cases.
Ferri C, de Pinto M, Murdaca G, De Luca G, Beigi DMR, Caira V, Foti R, Cito A, Naclerio C, Luppino JME, Spinella A, Orlandi M, Batani V, Lumetti F, Prampolini F, Varcasia G, Foti R, Riccieri V, Iannone F, Antonelli A, Giuggioli D, COVID‐19 and Autoimmune Systemic Diseases Italian Study Group.   +21 more
europepmc   +2 more sources

Inclusivity in clinical trials. [PDF]

Reumatologia
Maślińska M.
europepmc   +1 more source

Navigating the gap: the challenge of applying treat-to-target in routine lupus care-a national perspective. [PDF]

Lupus Sci Med
Castrejón I, Galindo-Izquierdo M, Gómez S, Manrique-Arija S, Romero-Yuste S, Vela P, Loza E, Otón T, Marras C, T2T Lupus Spain Working Group.   +9 more
europepmc   +1 more source

Reumatología

Iatreia, 2005
Olga Gómez Zuluaga
doaj  

Metastatic Crohn's disease as a granulomatous bridge between gastroenterology, rheumatology and dermatology. [PDF]

Reumatologia
Nitskovich R, Lewandowski K, Walecka I.
europepmc   +1 more source

Allopurinol in chronic kidney disease: navigating between pathophysiology, experimental evidence, and real-world challenges. [PDF]

J Bras Nefrol
Vargas-Santos AB, Telles RW, Castelar-Pinheiro GDR.   +2 more
europepmc   +1 more source

Evaluation of routine coagulation profiles and hematological markers in patients with extremity sarcomas: A cohort study. [PDF]

Hematol Transfus Cell Ther
Lovato GF, Penteado JPR, Branco E Silva M, Montalvão SAL, Hubers SC, Bizzacchi JMA, Mouraria GG, Etchebehere M.   +7 more
europepmc   +1 more source

Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohort. [PDF]

Lupus Sci Med
Pons-Estel GJ, Nieto RE, Quintana R, Serrano Morales R, Borba EF, Hernández L, Harvey GB, Roberts K, Fernández-Ávila DC, Scolnik M, Funes Soaje C, Otaduy C, Saurit V, Arturi V, Berbotto GA, González Lucero L, Kerzberg E, Gómez GN, Pisoni CN, Juárez V, Martínez Serventi J, Isnardi CA, Parente Costa Seguro L, Montadon ACOS, Monticielo OA, Mariz HA, Machado Ribeiro F, Dos Reis-Neto ET, Guerra I, Massardo L, Aroca Martínez G, Iglesias Gamarra A, Cañas CA, Quintana López G, Toro Gutiérrez CE, Moreno Álvarez MJ, Saavedra MA, Portela Hernández M, Pérez Cristóbal M, Fragoso Loyo H, Juárez-Vicuña Y, González-Bello YC, Abud-Mendoza C, Esquivel-Valerio JA, Langjahr P, Paats A, Mora Trujillo C, Ugarte-Gil MF, Calvo-Quiroz A, Muñoz Louis R, Rebella M, Danza Á, Sbarigia U, Zazzetti F, Orillion A, Gómez Puerta JA, Alarcon GS, Pons-Estel BA.   +57 more
europepmc   +1 more source

Seronegative polymyalgia rheumatica: an update. [PDF]

Reumatologia
Manzo C.
europepmc   +1 more source

Late-onset systemic sclerosis: current concepts, uncertainties, and future practice guidelines. [PDF]

Reumatologia
Baimukhamedov C, Assanova G.
europepmc   +1 more source